THIS PAGE IS UNDER CONSTRUCTION
Related Pages
References
Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D. Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010 Jun;9(6):573-80. PubMed PMID: 20452823.
Barone P, Scarzella L, Marconi R, Antonini A, Morgante L, Bracco F, Zappia M, Musch B; Depression/Parkinson Italian Study Group. Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease: a national multicenter parallel-group randomized study. J Neurol. 2006 May;253(5):601-7. PubMed PMID: 16607468.
Fernandez HH, Merello M. Pramipexole for depression and motor symptoms in Parkinson’s disease: can we kill two birds with one stone? Lancet Neurol. 2010 Jun;9(6):556-7. PubMed PMID: 20452824.
Harada T, Ishizaki F, Horie N, Nitta Y, Yamada T, Sasaki T, Nagakane T, Yasumatsu Y, Nitta K, Katsuoka H. New dopamine agonist pramipexole improves parkinsonism and depression in Parkinson’s disease. Hiroshima J Med Sci. 2011 Dec;60(4):79-82. PubMed PMID: 22389951.
Kano O, Ikeda K, Kiyozuka T, Iwamoto K, Ito H, Kawase Y, Sato R, Fujioka T, Araki Y, Baba S, Iwasaki Y. Beneficial effect of pramipexole for motor function and depression in Parkinson’s disease. Neuropsychiatr Dis Treat. 2008 Aug;4(4):707-10. PubMed PMID: 19043513; PubMed Central PMCID: PMC2536536.
Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ. The effect of pramipexole on mood and motivational symptoms in Parkinson’s disease: a meta-analysis of placebo-controlled studies. Clin Ther. 2009 Jan;31(1):89-98. Erratum in: Clin Ther. 2009 Mar;31(3):677. PubMed PMID: 19243709.
Lemke MR, Brecht HM, Koester J, Kraus PH, Reichmann H. Anhedonia, depression, and motor functioning in Parkinson’s disease during treatment with pramipexole. J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):214-20. PubMed PMID: 15939976.
Lemke MR, Brecht HM, Koester J, Reichmann H. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson’s disease. J Neurol Sci. 2006 Oct 25;248(1-2):266-70. Epub 2006 Jun 30. PubMed PMID: 16814808.
Yasui N, Sekiguchi K, Hamaguchi H, Kanda F. The effect of pramipexole on depressive symptoms in Parkinson’s disease. Kobe J Med Sci. 2011 Feb 2;56(5):E214-9. PubMed PMID: 21937869.
Copyright © 2018, Simple and Practical Mental Health. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.